68Ga-DOTATOC-PET/MRI and 11C-5-HTP-PET/MRI are superior to 68Ga-DOTATOC-PET/CT for neuroendocrine tumour imaging

被引:15
|
作者
Jawlakh, Hiba [1 ]
Velikyan, Irina [1 ]
Welin, Staffan [2 ]
Sundin, Anders [1 ]
机构
[1] Uppsala Univ, Dept Surg Sci Radiol & Mol Imaging, Uppsala, Sweden
[2] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
关键词
C-11-5-HTP; Ga-68-DOTATOC; detection rate; neuroendocrine tumour; PET/CT; PET/MRI; SUVmax; tumour-to-background ratio; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; POSITRON-EMISSION-TOMOGRAPHY; ENETS CONSENSUS GUIDELINES; CONTRAST-ENHANCED CT; GA-68-DOTA-TYR(3)-OCTREOTIDE PET; BONE METASTASES; PET/MRI; MANAGEMENT; DIAGNOSIS; DOTATOC;
D O I
10.1111/jne.12981
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study aimed to assess gadoxetate disodium contrast-enhanced (CE) positron emission tomography (PET)/magnetic resonance imaging (MRI) with Ga-68-DOTATOC and C-11-5-Hydroxy-tryptophan (C-11-5-HTP) in comparison with iodine CE Ga-68-DOTATOC-PET/computed tomography (CT) for neuroendocrine tumour imaging. Detection rate and reader's confidence were evaluated for each separate image volume: CE-CT, CE-MRI including diffusion-weighted imaging, Ga-68-DOTATOC-PET performed at PET/CT, Ga-68-DOTATOC-PET performed at PET/MRI and C-11-5-HTP-PET, and for the three combined hybrid examinations Ga-68-DOTATOC-PET/MRI, C-11-5-HTP-PET/MRI and Ga-68-DOTATOC-PET/CT. In 11 patients, 255 lesions were depicted. Ga-68-DOTATOC-PET performed at PET/MRI depicted 72.5%, Ga-68-DOTATOC-PET performed at PET/CT depicted 62.7%, C-11-5-HTP-PET depicted 68.2% and CE-CT depicted 53% of lesions. Ga-68-DOTATOC-PET performed at PET/MRI (P < 0.001) and PET/CT (P = 0.02), C-11-5-HTP-PET (P < 0.001) and MRI (P < 0.001) were superior to CT. Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI detected 92.5% and 92% of lesions, respectively, and both outperformed Ga-68-DOTATOC-PET/CT (65%) (P < 0.001). For liver metastasis imaging, MRI alone was unsurpassed (P < 0.01) and Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI outperformed Ga-68-DOTATOC-PET/CT (P < 0.001). For lymph node metastasis diagnosis, Ga-68-DOTATOC-PET performed at PET/MRI and PET/CT and C-11-5-HTP-PET detected 94%, 94% and 94% of lesions, respectively, and outperformed MRI and CE-CT alone (P < 0.001). For bone metastasis imaging, Ga-68-DOTATOC-PET performed at PET/MRI and PET/CT and C-11-5-HTP-PET performed equally well (P = 0.05) and better than MRI. Reader's confidence was better for Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI than for Ga-68-DOTATOC-PET/CT. The tumour maximum standardised uptake value and tumour-to-liver ratio were both approximately twice as high as for Ga-68-DOTATOC than for C-11-5-HTP. Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI provided the highest detection rates and reader's confidence and were both superior to Ga-68-DOTATOC-PET/CT, mainly because of the MRI component. The imaging contrast with Ga-68-DOTATOC was superior to that of C-11-5-HTP.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Simultaneous 68Ga-DOTATOC-PET/MRI for characterization of undetermined upper abdominal tracer uptake in 68Ga-DOTATOC PET/CT
    Sabet, Amir
    Cohnen, Joseph
    Beiderwellen, Karsten
    Ezziddin, Samer
    Umutlu, Lale
    Bellendorf, Alexander
    Grafe, Hong
    Nensa, Felix
    Bockisch, Andreas
    Poeppel, Thorsten
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [2] Wandering spleen on a 68Ga-DOTATOC-PET/CT scan
    Nele Lips
    Christophe M. Deroose
    Didier Bielen
    Peter Bossuyt
    Luc Mortelmans
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 982 - 982
  • [3] Target Volume Definition With 68GA-DOTATOC-PET/CT And MRI For Patients With Meningiomas
    Colandrea, M.
    Garibaldi, C.
    Ferrari, M. E.
    Iannalfi, A.
    Pesente, S.
    Fracassi, S. L.
    Gilardi, L.
    Rocca, A. P.
    Travaini, L. L.
    Militano, D.
    Papi, S.
    Cascio, A. S.
    Cremonesi, M.
    Grana, C. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S392 - S392
  • [4] Meningiomas as Incidentalomas Visualized on 68Ga-DOTATOC-PET/CT
    Alevroudis, E.
    Liotsou, T.
    Metaxas, M.
    Tsoli, M.
    Anagnostou, E.
    Kaltsas, G.
    Chatziioannou, S. N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S271 - S271
  • [5] Detection of cranial meningiomas. Comparison of 68Ga-DOTATOC-PET/CT and MRI
    Afshar-Oromieh, Ali
    Kratochwil, Clemens
    Linhart, Heinz G.
    Haberkorn, Uwe
    Giesel, Frederik
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [6] Wandering spleen on a 68Ga-DOTATOC-PET/CT scan
    Lips, Nele
    Deroose, Christophe M.
    Bielen, Didier
    Bossuyt, Peter
    Mortelmans, Luc
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (05) : 982 - 982
  • [7] Target volume definition with MRI and 68Ga-DOTATOC-PET/CT for patients with meningiomas
    Garibaldi, C.
    Ferrari, M.
    Colandrea, M.
    Cascio, A.
    Ciocca, M.
    Iannalfi, A.
    D'Ippolito, E.
    Pesente, S.
    Grana, C.
    Cremonesi, M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1160 - S1160
  • [8] Comparison of 68Ga-DOTATOC-PET/CT and whole-body MRI in staging of neuroendocrine tumors
    Pfannenberg, Christina
    Schwenzer, Nina
    Werner, Matthias
    Sperling, Olga
    Mueller, Mark
    Claussen, Claus
    Bares, Roland
    Schraml, Christina
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [9] 68Ga-DOTATOC-PET/CT detects neuroendocrine differentiation of prostate cancer metastases
    Souvatzoglou, M.
    Maurer, T.
    Treiber, U.
    Weirich, G.
    Krause, B. J.
    Essler, M.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2009, 48 (05): : N52 - N54
  • [10] Comparison of 68Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results
    Afshar-Oromieh, Ali
    Wolf, Maya B.
    Kratochwil, Clemens
    Giesel, Frederik L.
    Combs, Stephanie E.
    Dimitrakopoulou-Strauss, Antonia
    Gnirs, Regula
    Roethke, Matthias C.
    Schlemmer, Heinz P.
    Haberkorn, Uwe
    NEURO-ONCOLOGY, 2015, 17 (02) : 312 - 319